Back to News
Market Impact: 0.2
BioAffinity Prices $4 Mln Direct Offering, Adds Warrants To Support CyPath Lung Sales
Source: Nasdaq
Healthcare & BiotechCompany FundamentalsPrivate Markets & Venture
bioAffinity Technologies agreed to raise approximately $4 million through a registered direct offering, alongside a concurrent private placement of warrants. The article provides no further terms or stated use of proceeds.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
-0.10
Ticker Sentiment
BIAF-0.20
More News
- Wall Street Week | Michigan Manufacturing, AI Debt Investments, Baby Bonds, Canadian Coal Fight
- Tesla drops 'Full Self-Driving' brand name in Europe after regulator pushback
- SpaceX makes big move into wireless. These once 'obsolete' tech stocks could benefit
- MTY Food Group Inc Profit Retreats In Q3
- Why is T-Mobile stock tumbling today?
- Wall Street sees buying opportunity in banks as shares tank ahead of earnings